VHT holdings
Vanguard Health Care ETF
Positions
407 stored of 407 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 201 | Syndax Pharmaceuticals Inc | US87164F1057 | 87164F105 | 0.025% | $4.8M | Equity (common) | Corporate | United States | USD |
| 202 | Recursion Pharmaceuticals Inc RECURSION PHAR-A | US75629V1044 | 75629V104 | 0.025% | $4.8M | Equity (common) | Corporate | United States | USD |
| 203 | Perrigo Co PLC | IE00BGH1M568 | G97822103 | 0.024% | $4.6M | Equity (common) | Corporate | United States | USD |
| 204 | Innoviva Inc | US45781M1018 | 45781M101 | 0.024% | $4.6M | Equity (common) | Corporate | United States | USD |
| 205 | Newamsterdam Pharma Co NV | NL00150012L7 | Not reported | 0.024% | $4.6M | Equity (common) | Corporate | United States | USD |
| 206 | Novavax Inc | US6700024010 | 670002401 | 0.024% | $4.6M | Equity (common) | Corporate | United States | USD |
| 207 | Procept Biorobotics Corp | US74276L1052 | 74276L105 | 0.023% | $4.4M | Equity (common) | Corporate | United States | USD |
| 208 | Ardelyx Inc | US0396971071 | 039697107 | 0.023% | $4.4M | Equity (common) | Corporate | United States | USD |
| 209 | Mineralys Therapeutics Inc | US6031701013 | 603170101 | 0.023% | $4.3M | Equity (common) | Corporate | United States | USD |
| 210 | Ocular Therapeutix Inc | US67576A1007 | 67576A100 | 0.023% | $4.3M | Equity (common) | Corporate | United States | USD |
| 211 | Biohaven Ltd | VGG1110E1079 | G1110E107 | 0.023% | $4.3M | Equity (common) | Corporate | United States | USD |
| 212 | Fortrea Holdings Inc | US34965K1079 | 34965K107 | 0.022% | $4.3M | Equity (common) | Corporate | United States | USD |
| 213 | ANI Pharmaceuticals Inc | US00182C1036 | 00182C103 | 0.022% | $4.2M | Equity (common) | Corporate | United States | USD |
| 214 | Alumis Inc | US0223071020 | 022307102 | 0.022% | $4.2M | Equity (common) | Corporate | United States | USD |
| 215 | AtriCure Inc | US04963C2098 | 04963C209 | 0.022% | $4.1M | Equity (common) | Corporate | United States | USD |
| 216 | Harmony Biosciences Holdings Inc | US4131971040 | 413197104 | 0.022% | $4.1M | Equity (common) | Corporate | United States | USD |
| 217 | Vera Therapeutics Inc | US92337R1014 | 92337R101 | 0.022% | $4.1M | Equity (common) | Corporate | United States | USD |
| 218 | NeoGenomics Inc | US64049M2098 | 64049M209 | 0.021% | $4.1M | Equity (common) | Corporate | United States | USD |
| 219 | Nurix Therapeutics Inc | US67080M1036 | 67080M103 | 0.021% | $4.1M | Equity (common) | Corporate | United States | USD |
| 220 | Trevi Therapeutics Inc | US89532M1018 | 89532M101 | 0.021% | $4.1M | Equity (common) | Corporate | United States | USD |
| 221 | Teladoc Health Inc | US87918A1051 | 87918A105 | 0.021% | $4.1M | Equity (common) | Corporate | United States | USD |
| 222 | LifeStance Health Group Inc | US53228F1012 | 53228F101 | 0.021% | $4.0M | Equity (common) | Corporate | United States | USD |
| 223 | Enovis Corp | US1940145022 | 194014502 | 0.021% | $3.9M | Equity (common) | Corporate | United States | USD |
| 224 | Enliven Therapeutics Inc | US29337E1029 | 29337E102 | 0.020% | $3.9M | Equity (common) | Corporate | United States | USD |
| 225 | Iovance Biotherapeutics Inc | US4622601007 | 462260100 | 0.020% | $3.8M | Equity (common) | Corporate | United States | USD |
| 226 | Stoke Therapeutics Inc | US86150R1077 | 86150R107 | 0.020% | $3.7M | Equity (common) | Corporate | United States | USD |
| 227 | Establishment Labs Holdings Inc | VGG312491084 | G31249108 | 0.020% | $3.7M | Equity (common) | Corporate | United States | USD |
| 228 | Pennant Group Inc/The PENNANT GROUP-WI | US70805E1091 | 70805E109 | 0.019% | $3.6M | Equity (common) | Corporate | United States | USD |
| 229 | Tandem Diabetes Care Inc | US8753722037 | 875372203 | 0.018% | $3.5M | Equity (common) | Corporate | United States | USD |
| 230 | Inspire Medical Systems Inc | US4577301090 | 457730109 | 0.018% | $3.5M | Equity (common) | Corporate | United States | USD |
| 231 | Pieris Pharmaceuticals Inc PALVELLA THERAPE | US6979471090 | 697947109 | 0.018% | $3.5M | Equity (common) | Corporate | United States | USD |
| 232 | CareDx Inc | US14167L1035 | 14167L103 | 0.018% | $3.5M | Equity (common) | Corporate | United States | USD |
| 233 | Avanos Medical Inc | US05350V1061 | 05350V106 | 0.018% | $3.5M | Equity (common) | Corporate | United States | USD |
| 234 | agilon health Inc | US00857U2069 | 00857U206 | 0.018% | $3.4M | Equity (common) | Corporate | United States | USD |
| 235 | Viridian Therapeutics Inc | US92790C1045 | 92790C104 | 0.018% | $3.4M | Equity (common) | Corporate | United States | USD |
| 236 | Rapport Therapeutics Inc | US75383L1026 | 75383L102 | 0.018% | $3.4M | Equity (common) | Corporate | United States | USD |
| 237 | Vir Biotechnology Inc | US92764N1028 | 92764N102 | 0.018% | $3.4M | Equity (common) | Corporate | United States | USD |
| 238 | AMN Healthcare Services Inc | US0017441017 | 001744101 | 0.018% | $3.3M | Equity (common) | Corporate | United States | USD |
| 239 | CONMED Corp | US2074101013 | 207410101 | 0.018% | $3.3M | Equity (common) | Corporate | United States | USD |
| 240 | UroGen Pharma Ltd | IL0011407140 | M96088105 | 0.018% | $3.3M | Equity (common) | Corporate | United States | USD |
| 241 | Harrow Inc | US4158581094 | 415858109 | 0.018% | $3.3M | Equity (common) | Corporate | United States | USD |
| 242 | MannKind Corp | US56400P7069 | 56400P706 | 0.017% | $3.3M | Equity (common) | Corporate | United States | USD |
| 243 | Collegium Pharmaceutical Inc | US19459J1043 | 19459J104 | 0.017% | $3.2M | Equity (common) | Corporate | United States | USD |
| 244 | Kodiak Sciences Inc | US50015M1099 | 50015M109 | 0.017% | $3.2M | Equity (common) | Corporate | United States | USD |
| 245 | Integra LifeSciences Holdings Corp | US4579852082 | 457985208 | 0.017% | $3.2M | Equity (common) | Corporate | United States | USD |
| 246 | Nuvation Bio Inc | US67080N1019 | 67080N101 | 0.017% | $3.2M | Equity (common) | Corporate | United States | USD |
| 247 | GeneDx Holdings Corp | US81663L2007 | 81663L200 | 0.017% | $3.2M | Equity (common) | Corporate | United States | USD |
| 248 | Surgery Partners Inc | US86881A1007 | 86881A100 | 0.016% | $3.1M | Equity (common) | Corporate | United States | USD |
| 249 | Xeris Biopharma Holdings Inc | US98422E1038 | 98422E103 | 0.016% | $3.1M | Equity (common) | Corporate | United States | USD |
| 250 | EyePoint Inc | US30233G2093 | 30233G209 | 0.016% | $3.0M | Equity (common) | Corporate | United States | USD |
| 251 | BioLife Solutions Inc | US09062W2044 | 09062W204 | 0.016% | $3.0M | Equity (common) | Corporate | United States | USD |
| 252 | Schrodinger Inc/United States | US80810D1037 | 80810D103 | 0.016% | $3.0M | Equity (common) | Corporate | United States | USD |
| 253 | New Issuer: BB Company ID:54419104 HINGE HEALTH-A | US4333131039 | 433313103 | 0.016% | $3.0M | Equity (common) | Corporate | United States | USD |
| 254 | Tango Therapeutics Inc | US87583X1090 | 87583X109 | 0.015% | $2.9M | Equity (common) | Corporate | United States | USD |
| 255 | US Physical Therapy Inc | US90337L1089 | 90337L108 | 0.015% | $2.9M | Equity (common) | Corporate | United States | USD |
| 256 | STAAR Surgical Co | US8523123052 | 852312305 | 0.015% | $2.9M | Equity (common) | Corporate | United States | USD |
| 257 | AdaptHealth Corp | US00653Q1022 | 00653Q102 | 0.015% | $2.9M | Equity (common) | Corporate | United States | USD |
| 258 | Azenta Inc | US1143401024 | 114340102 | 0.015% | $2.9M | Equity (common) | Corporate | United States | USD |
| 259 | Pacira BioSciences Inc | US6951271005 | 695127100 | 0.015% | $2.9M | Equity (common) | Corporate | United States | USD |
| 260 | Amylyx Pharmaceuticals Inc | US03237H1014 | 03237H101 | 0.015% | $2.8M | Equity (common) | Corporate | United States | USD |
| 261 | New Issuer: BB Company ID:69588108 GUARDIAN PHARM-A | US40145W1018 | 40145W101 | 0.015% | $2.8M | Equity (common) | Corporate | United States | USD |
| 262 | Zymeworks Inc | US98985Y1082 | 98985Y108 | 0.015% | $2.8M | Equity (common) | Corporate | United States | USD |
| 263 | Butterfly Network Inc | US1241551027 | 124155102 | 0.015% | $2.8M | Equity (common) | Corporate | United States | USD |
| 264 | Alphatec Holdings Inc | US02081G2012 | 02081G201 | 0.015% | $2.8M | Equity (common) | Corporate | United States | USD |
| 265 | Artivion Inc | US2289031005 | 228903100 | 0.014% | $2.7M | Equity (common) | Corporate | United States | USD |
| 266 | QuidelOrtho Corp | US2197981051 | 219798105 | 0.014% | $2.7M | Equity (common) | Corporate | United States | USD |
| 267 | Taysha Gene Therapies Inc | US8776191061 | 877619106 | 0.013% | $2.4M | Equity (common) | Corporate | United States | USD |
| 268 | Kura Oncology Inc | US50127T1097 | 50127T109 | 0.012% | $2.4M | Equity (common) | Corporate | United States | USD |
| 269 | Omeros Corp | US6821431029 | 682143102 | 0.012% | $2.4M | Equity (common) | Corporate | United States | USD |
| 270 | AnaptysBio Inc | US0327241065 | 032724106 | 0.012% | $2.3M | Equity (common) | Corporate | United States | USD |
| 271 | Precigen Inc | US74017N1054 | 74017N105 | 0.012% | $2.3M | Equity (common) | Corporate | United States | USD |
| 272 | iRadimed Corp | US46266A1097 | 46266A109 | 0.012% | $2.2M | Equity (common) | Corporate | United States | USD |
| 273 | Esperion Therapeutics Inc | US29664W1053 | 29664W105 | 0.012% | $2.2M | Equity (common) | Corporate | United States | USD |
| 274 | KalVista Pharmaceuticals Inc | US4834971032 | 483497103 | 0.012% | $2.2M | Equity (common) | Corporate | United States | USD |
| 275 | CryoPort Inc | US2290503075 | 229050307 | 0.012% | $2.2M | Equity (common) | Corporate | United States | USD |
| 276 | Talkspace Inc | US87427V1035 | 87427V103 | 0.012% | $2.2M | Equity (common) | Corporate | United States | USD |
| 277 | WaVe Life Sciences Ltd | SG9999014716 | Y95308105 | 0.012% | $2.2M | Equity (common) | Corporate | United States | USD |
| 278 | MBX Biosciences Inc | US55287L1017 | 55287L101 | 0.011% | $2.1M | Equity (common) | Corporate | United States | USD |
| 279 | Certara Inc | US15687V1098 | 15687V109 | 0.011% | $2.1M | Equity (common) | Corporate | United States | USD |
| 280 | Amphastar Pharmaceuticals Inc | US03209R1032 | 03209R103 | 0.011% | $2.1M | Equity (common) | Corporate | United States | USD |
| 281 | Aura Biosciences Inc | US05153U1079 | 05153U107 | 0.011% | $2.1M | Equity (common) | Corporate | United States | USD |
| 282 | Corvus Pharmaceuticals Inc | US2210151005 | 221015100 | 0.011% | $2.1M | Equity (common) | Corporate | United States | USD |
| 283 | Arbutus Biopharma Corp | CA03879J1003 | 03879J100 | 0.011% | $2.1M | Equity (common) | Corporate | United States | USD |
| 284 | Annexon Inc | US03589W1027 | 03589W102 | 0.010% | $1.9M | Equity (common) | Corporate | United States | USD |
| 285 | Tilray Brands Inc | US88688T2096 | 88688T209 | 0.010% | $1.9M | Equity (common) | Corporate | United States | USD |
| 286 | ArriVent Biopharma Inc | US04272N1028 | 04272N102 | 0.010% | $1.9M | Equity (common) | Corporate | United States | USD |
| 287 | Phibro Animal Health Corp PHIBRO ANIMAL-A | US71742Q1067 | 71742Q106 | 0.010% | $1.9M | Equity (common) | Corporate | United States | USD |
| 288 | CorMedix Inc | US21900C3088 | 21900C308 | 0.010% | $1.9M | Equity (common) | Corporate | United States | USD |
| 289 | OPKO Health Inc | US68375N1037 | 68375N103 | 0.010% | $1.8M | Equity (common) | Corporate | United States | USD |
| 290 | Castle Biosciences Inc | US14843C1053 | 14843C105 | 0.010% | $1.8M | Equity (common) | Corporate | United States | USD |
| 291 | Monte Rosa Therapeutics Inc | US61225M1027 | 61225M102 | 0.010% | $1.8M | Equity (common) | Corporate | United States | USD |
| 292 | MoonLake Immunotherapeutics | KY61559X1045 | 61559X104 | 0.010% | $1.8M | Equity (common) | Corporate | United States | USD |
| 293 | Theravance Biopharma Inc | KYG8807B1068 | G8807B106 | 0.010% | $1.8M | Equity (common) | Corporate | United States | USD |
| 294 | Personalis Inc | US71535D1063 | 71535D106 | 0.010% | $1.8M | Equity (common) | Corporate | United States | USD |
| 295 | Bicara Therapeutics Inc | US0554771032 | 055477103 | 0.009% | $1.8M | Equity (common) | Corporate | United States | USD |
| 296 | Geron Corp | US3741631036 | 374163103 | 0.009% | $1.8M | Equity (common) | Corporate | United States | USD |
| 297 | HealthStream Inc | US42222N1037 | 42222N103 | 0.009% | $1.8M | Equity (common) | Corporate | United States | USD |
| 298 | Phreesia Inc | US71944F1066 | 71944F106 | 0.009% | $1.8M | Equity (common) | Corporate | United States | USD |
| 299 | Cerus Corp | US1570851014 | 157085101 | 0.009% | $1.8M | Equity (common) | Corporate | United States | USD |
| 300 | Xencor Inc | US98401F1057 | 98401F105 | 0.009% | $1.8M | Equity (common) | Corporate | United States | USD |